Influence of the first wave of COVID-19 on asthma inhaler prescriptions.
Journal
NPJ primary care respiratory medicine
ISSN: 2055-1010
Titre abrégé: NPJ Prim Care Respir Med
Pays: England
ID NLM: 101631999
Informations de publication
Date de publication:
25 11 2021
25 11 2021
Historique:
received:
21
05
2021
accepted:
03
11
2021
entrez:
26
11
2021
pubmed:
27
11
2021
medline:
15
12
2021
Statut:
epublish
Résumé
In the beginning of the COVID-19 pandemic, there were major concerns regarding the huge demand for asthma inhalers. Using the primary-care medical records for 614,700 asthma patients between January and June 2020, we found that there was a substantial increase in inhalers solely in March 2020. Patients significantly associated with receiving higher inhaled corticosteroid prescriptions were younger, of higher socioeconomic status, and had milder asthma.
Identifiants
pubmed: 34824265
doi: 10.1038/s41533-021-00260-w
pii: 10.1038/s41533-021-00260-w
pmc: PMC8617286
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
45Informations de copyright
© 2021. The Author(s).
Références
Int J Epidemiol. 2015 Jun;44(3):827-36
pubmed: 26050254
BMJ Open. 2017 Aug 11;7(8):e017474
pubmed: 28801439
Br J Clin Pharmacol. 2018 Nov;84(11):2562-2571
pubmed: 29975799
Thorax. 2021 Sep;76(9):860-866
pubmed: 33782080